CASMED Announces Second Quarter 2013 Financial Results

Launch of Next-Generation Vital Signs Monitor Underway

Conference Call Begins at 10:00 a.m. ET Today

Branford, Conn. (August 7, 2013) - CAS Medical Systems, Inc. (NASDAQ: CASM), (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported financial results for the three months ended June 30, 2013. Net sales were $5.0 million for the second quarter of 2013, compared with $5.2 million for the second quarter of 2012. The net loss applicable to common stockholders for the second quarter of 2013 was $2.9 million, or ($0.22) per common share, compared with a net loss applicable to common stockholders of $1.9 million, or ($0.15) per common share, for the second quarter of 2012.

Highlights of the second quarter of 2013 and recent weeks include (all comparisons are with the second quarter of 2012):

  • Growing FORE-SIGHT

© Publicnow - 2013